No Data
No Data
Bubs Australia Reports Strong US Sales and Rebounding Chinese Market
Organic infant formula manufacturer Bubs Australia (ASX: BUB) has reported continued strong performance of its product range in the US market.
The Past Five Years for Bubs Australia (ASX:BUB) Investors Has Not Been Profitable
Bubs Australia Needs Strong 4Q to Hit Target -- Market Talk
0424 GMT - Bubs Australia's softer-than-expected 3Q leaves the infant-formula supplier requiring a strong finish to its fiscal year to hit its A$100 million annual sales target, Bell Potter analyst Jo
Bubs Australia Target Price Raised 7.1% to A$0.15/Share by Bell Potter>BUB.AU
Bubs Australia Target Price Raised 7.1% to A$0.15/Share by Bell Potter>BUB.AU
Bubs Australia Posts Continuing Sales Growth in US Market
Infant formula company Bubs Australia (ASX:BUB) said it continued to see growth in the US market, posting a 161% year over year increase in scan sales for the quarter ended Feb. 25. On a quarterly bas
Why Arafura, Bubs, Clinuvel, and Superloop Shares Are Racing Higher Today
The S&P/ASX 200 Index (ASX: XJO) is having a subdued session on Thursday. In afternoon trade, the benchmark index is down 0.2% to 7,715.8 points.
No Data